A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists is an effective and cost-saving strategy for long-term weight maintenance.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs ... Some pens are single-use and contain a premeasured dose of the GLP-1 RA. In other cases, you select the amount of medication to be injected.

But if you are already taking insulin, you may be able to decrease your dose (or maybe stop it completely) if taking a GLP-1 agonist is effective, Neumiller says. Work with your healthcare team to ...

while Wegovy (2.4 mg dose) costs about $1,350 without insurance, according to the Peterson-KFF Health System Tracker. In addition, due to increased demand, many GLP-1 agonists are listed on the ...

but with a much-reduced dose. That is the finding from a retrospective study reported at the European Congress on Obesity this week, which focused on the use of Novo Nordisk's GLP-1 agonist Wegovy ...

In GLP-1 receptor agonist-naive patients starting the generic liraglutide, once daily, adherence may not be a concern. However, for people who may switch from a once-weekly to a once-daily dosing ...

The small-scale, 28-day study saw 36 healthy adults with obesity or overweight receive one of three oral doses of the GLP-1 agonist ... 740 mg, dose of TERN-601 saw a placebo-adjusted mean ...

Hyperkalemia in type 2 diabetes occurred less often with GLP-1 receptor agonists in routine care than ... many studies show that hyperkalemia often leads to dose reduction or discontinuation ...

They also highlight the need for future clinical trials to more conclusively determine the dose and duration of GLP-1 receptor agonist-based treatments in patients addicted to different types of ...